• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Daiichi Sankyo

Cholesterol
MedTech

Daiichi pens pact for high cholesterol digital therapeutic

Daiichi Sankyo’s European division is teaming up with German medtech Gaia to sell the latter company’s cardiovascular digital therapeutic lipodia.
Ben Adams Mar 5, 2026 9:20am
weigh scale goliath outweigh balance bigger smaller even

BioNTech’s B7-H3 ADC hits ph. 3 at half the size of Merck’s

Feb 27, 2026 10:31pm
Parachute over a mountain in Switzerland

Sarepta CEO to step down as DM1 hits home—Chutes & Ladders

Feb 27, 2026 8:30am
Daiichi

Daiichi picks former Novartis CMO John Tsai to head up R&D

Feb 20, 2026 4:56am
Make a delay and accumulation of outstanding tasks Full stop

Daiichi stops internal development of next-wave ADC

Feb 2, 2026 10:55am
pause halt pause button

Daiichi-Merck ph. 3 ADC program on pause after patient deaths

Dec 18, 2025 11:22am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings